Dr. Poonam Beniwal-Patel, MD

Dr. Beniwal-Patel practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Beniwal-Patel's NPI, 1760617484, was assigned on May 26, 2009. Dr. Beniwal-Patel holds Wisconsin license 55723.

Dr. Beniwal-Patel's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Beniwal-Patel's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Beniwal-Patel is also affiliated with Froedtert West Bend Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Beniwal-Patel to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beniwal-Patel practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Beniwal-Patel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Beniwal-Patel is licensed in Wisconsin.

CMS data shows 190 Medicare services from Dr. Beniwal-Patel across 9 procedure codes in 2024, for 127 Medicare patients. Medicare paid $13,789 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Dr. Beniwal-Patel in 2024. The largest group is 65 to 74, with 59 patients. 64% of them have high cholesterol, and 59% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beniwal-Patel's median patient age at 47, with 64% women.

In 2024, Dr. Beniwal-Patel wrote 266 Medicare Part D claims for 94 patients. 59% of them were for generic drugs. CMS names the drug for 118 of them, across 7 drugs with 11 or more claims each, at $1,130,262 in total drug cost. In 2023, CMS named 162 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Beniwal-Patel for performance year 2024, reported as part of a group. Dr. Beniwal-Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beniwal-Patel as offering telehealth. CMS counts 35 procedures of colonoscopy by Dr. Beniwal-Patel, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Beniwal-Patel, published from 2014 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Crohn Disease, Brain and Remission Induction. Dr. Beniwal-Patel has published most often in Crohns Colitis 360. Dr. Beniwal-Patel's most frequent co-authors are Sumona Saha, MD, Parakkal Deepak, MD and Vivek Prabhakaran, MD, PhD.

Dmand AI links Dr. Beniwal-Patel to 2 clinical trials. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases.

CMS Open Payments shows 96 general payments to Dr. Beniwal-Patel from 8 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Abbvie Inc. paid the most, $61,837. It also lists 4 research payments totaling $130 in 2019.